Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Aggregation Inhibitors | 1 | 2016 | 35 | 0.500 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 89 | 0.490 |
Why?
|
| Stents | 5 | 2004 | 62 | 0.340 |
Why?
|
| Strontium Radioisotopes | 4 | 2003 | 8 | 0.260 |
Why?
|
| Beta Particles | 3 | 2003 | 7 | 0.250 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2002 | 14 | 0.240 |
Why?
|
| Myocardial Infarction | 3 | 2016 | 102 | 0.180 |
Why?
|
| Coronary Restenosis | 3 | 2004 | 10 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 155 | 0.120 |
Why?
|
| Hemorrhage | 1 | 2016 | 66 | 0.120 |
Why?
|
| Risk | 1 | 2016 | 199 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2004 | 29 | 0.120 |
Why?
|
| Brachytherapy | 3 | 2004 | 44 | 0.110 |
Why?
|
| Coronary Stenosis | 2 | 2004 | 9 | 0.110 |
Why?
|
| Stroke | 1 | 2016 | 254 | 0.100 |
Why?
|
| Coronary Angiography | 3 | 2004 | 50 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2004 | 1612 | 0.070 |
Why?
|
| Myocardial Revascularization | 2 | 2004 | 12 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2004 | 1671 | 0.060 |
Why?
|
| Humans | 8 | 2016 | 24703 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2003 | 14 | 0.060 |
Why?
|
| Myocardial Stunning | 1 | 2004 | 2 | 0.060 |
Why?
|
| Laser Therapy | 1 | 2004 | 10 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2004 | 24 | 0.060 |
Why?
|
| Calcinosis | 1 | 2004 | 37 | 0.050 |
Why?
|
| Lymphokines | 1 | 2003 | 7 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 7 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 29 | 0.050 |
Why?
|
| DNA | 1 | 2003 | 97 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 29 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 50 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2003 | 84 | 0.050 |
Why?
|
| Visual Perception | 1 | 2002 | 28 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2004 | 3208 | 0.050 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 6 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 9 | 0.050 |
Why?
|
| Middle Aged | 6 | 2004 | 8294 | 0.050 |
Why?
|
| Aged | 6 | 2004 | 8382 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 121 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 193 | 0.040 |
Why?
|
| Male | 5 | 2004 | 13669 | 0.030 |
Why?
|
| Female | 5 | 2004 | 14048 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 814 | 0.030 |
Why?
|
| Survival Rate | 2 | 2004 | 285 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2003 | 250 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 412 | 0.020 |
Why?
|
| Swine | 1 | 2004 | 63 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 55 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 125 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2003 | 3156 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 5 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 99 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 10 | 0.010 |
Why?
|
| Injections | 1 | 2003 | 42 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2003 | 26 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 21 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 20 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 365 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 67 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 103 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 370 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 94 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 145 | 0.010 |
Why?
|
| Death | 1 | 2003 | 41 | 0.010 |
Why?
|
| Illinois | 1 | 2003 | 221 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 304 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 611 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 532 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 560 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 281 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 613 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 697 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 598 | 0.010 |
Why?
|
| Reoperation | 1 | 2002 | 879 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 3330 | 0.010 |
Why?
|
| Adult | 1 | 2003 | 7255 | 0.010 |
Why?
|